Revisiting biochemistry: severe euglycemic ketoacidosis in the setting of IDH‐inhibitor therapy for AML
Open Access
- 7 June 2021
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 194 (6) , 1083-1085
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Evaluating ivosidenib for the treatment of acute myeloid leukemiaExpert Opinion on Pharmacotherapy, 2020
- Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer TherapeuticsFrontiers in Oncology, 2019
- The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemiaTherapeutic Advances in Hematology, 2018